Note 17: Detailed Information - People Costs continued Valuation assumptions and fair values of equity instruments granted The model inputs for share-based payments granted during the year ended 30 June 2026 included: Performance Share Units (by grant date) 1 September 2025 - Tranche 1 $205.31 $215.07 — 17.5 % 24 months 2.4 % 3.35 % 1 September 2025 - Tranche 2 $199.71 $215.07 — 17.5 % 36 months 2.5 % 3.42 % 1 March 2026 - Tranche 1 $145.60 $146.54 — 22.5 % 6 months 1.3 % 4.05 % 1 March 2026 - Tranche 2 $140.39 $146.54 — 22.5 % 18 months 2.9 % 4.17 % 1 March 2026 - Tranche 3 $135.77 $146.54 — 22.5 % 30 months 3.1 % 4.22 % Restricted Share Units (by grant date) 1 September 2025 - Tranche 1 $212.74 $215.07 — 20.0 % 6 months 2.2 % 3.55 % 1 September 2025 - Tranche 2 $210.44 $215.07 — 20.0 % 12 months 2.2 % 3.40 % 1 September 2025 - Tranche 3 $207.71 $215.07 — 17.5 % 18 months 2.4 % 3.35 % 1 September 2025 - Tranche 4 $205.31 $215.07 — 17.5 % 24 months 5.4 % 3.35 % 1 September 2025 - Tranche 5 $202.19 $215.07 — 17.5 % 30 months 2.5 % 3.42 % 1 September 2025 - Tranche 6 $199.71 $215.07 — 17.5 % 36 months 2.5 % 3.42 % 1 March 2026 - Tranche 1 $145.60 $146.54 — 22.5 % 6 months 1.3 % 4.05 % 1 March 2026 - Tranche 2 $142.55 $146.54 — 22.5 % 12 months 2.8 % 4.15 % 1 March 2026 - Tranche 3 $140.39 $146.54 — 22.5 % 18 months 2.9 % 4.17 % 1 March 2026 - Tranche 4 $138.13 $146.54 — 22.5 % 24 months 3.0 % 4.17 % 1 March 2026 - Tranche 5 $135.77 $146.54 — 22.5 % 30 months 3.1 % 4.22 % Rights (by grant date) 27 August 2025 - Tranche 1 $217.28 $219.37 — 20.0 % 6 months 2.2 % 3.54 % 27 August 2025 - Tranche 2 $214.72 $219.37 — 20.0 % 12 months 2.2 % 3.39 % 19 February 2026 $151.50 $152.49 — 22.5 % 6 months 1.3 % 4.24 % GESP (by grant date) 8 September 2025 - Tranche 1 $30.56 $213.37 $182.81 20.0 % 6 months 2.2 % 3.55 % 6 March 2026 - Tranche 1 $21.71 $146.27 $124.56 22.5 % 6 months 1.3 % 4.05 % Fair Value (A$) Share Price (A$) Exercise Price (A$) Expected Volatility Life Assumption Expected Dividend Yield Risk-free Interest Rates 127 Notes to the Financial Statements 127 CSL Limited Annual Report 2025/26
RkJQdWJsaXNoZXIy MjE2NDg3